Wednesday, 31 May 2017

Public-Private Investments and Research Grants Offered for the Development of Surgical Laser Products

The report "Surgical Lasers Market by Product Type (Carbon Dioxide, Argon, Nd:YAG & Diode Lasers), Procedure (Open, Laparoscopic & Percutaneous), & Application (Ophthalmology, Urology, Gynaecology, Dermatology, Dental, Cardiology, & Oncology) - Global forecast to 2021” The surgical lasers market is expected to reach USD 2.37 Billion by 2021 from USD 1.85 Billion in 2016; growing at a CAGR of 5.1% during the forecast period.

Browse 75 market data tables and 55 figures spread through 166 pages and in-depth TOC on “Surgical Lasers Market"

http://www.marketsandmarkets.com/Market-Reports/surgical-laser-market-12712582.html

Early buyers will receive 10% customization on this report.

The rising demand for surgical lasers can be attributed to the growing prevalence of chronic diseases, technological advancements, increasing incidence and prevalence of targeted diseases, and high prevalence of ophthalmic disorders. In addition, growing preference for minimally invasive surgeries among patients and healthcare professionals is supporting the growth of the market.

Get The PDF Brochure For This Report@

http://www.marketsandmarkets.com/pdfdownload.asp?id=12712582

On the basis of type, the surgical lasers market is categorized into five segments, namely, carbon dioxide (CO2) lasers, argon lasers, Nd:YAG lasers, diode lasers, and other surgical lasers (fiber lasers, dye lasers, Er:YAG lasers, and excimer lasers). The carbon dioxide (CO2) lasers segment is growing at the highest CAGR in the market due to the widespread availability of innovative CO2-based surgical lasers and ongoing technological advancements in cosmetic laser treatment.

Based on procedure type, the market is segmented into open surgery, laparoscopic surgery, and percutaneous surgery. The laparoscopic surgery segment is expected to dominate the market. This growth can be primarily attributed to the procedural benefits of laparoscopic procedures and growing patient awareness and market demand for less-invasive disease therapies.

By application, the market is segmented into ophthalmology, dentistry, dermatology, cardiology, gynecology, urology, oncology, and other applications (liposuction, ENT, and GIT). The urology segment is expected to be the fastest-growing surgical laser application segment. Growth in this application segment can be attributed to the rising prevalence of urological disorders (such as kidney stones, renal cancer, and prostate enlargement), growing patient preference for minimally invasive urological surgeries, and ongoing technological advancements in surgical laser products.

Download Sample Pages of this Report@

http://www.marketsandmarkets.com/requestsample.asp?id=12712582

North America is expected to hold the largest share of the global surgical lasers market, followed by Europe in 2016. However, the Asia-Pacific market is expected to grow at the highest CAGR from 2016 to 2021. Factors driving market growth in the Asia-Pacific region include the presence of a large patient population for target diseases (coupled with rapidly growing geriatric population), rising awareness among healthcare professionals related to the procedural benefits of surgical laser products, and increasing government initiatives to reduce the burden of ophthalmic disorders.

As of 2015, Lumenis (Israel), Cynosure, Inc. (U.S.), Alma Lasers (Israel), IPG Photonics Corporation (U.S.), Abbott Laboratories, Inc. (U.S.), Boston Scientific Corporation (U.S.), Spectranetics Corporation (U.S.), Biolitec AG (Austria), Fotona d.o.o. (Slovenia), and BISON MEDICAL Co., Ltd. (South Korea) are some of the key players operating in the surgical lasers market

About MarketsandMarkets™:

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 5000 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:

Mr. Rohan

MarketsandMarkets™

701 Pike Street

Suite 2175, Seattle,

WA 98101, United States

Tel: 1-888-600-6441

Fertility Testing Devices Market Size, By Product, 2013–2020

The report "Fertility Testing Devices Market Product (Ovulation Prediction Kit & Fertility Monitor (Urine-based, Saliva-based, & Basal Body Temperature)), Mode of Purchase (Prescription & OTC), and Region - Global Forecast to 2020"The global fertility testing devices market was estimated at USD 151.0 Million in 2015; it is poised to grow at a CAGR of 7.5% during the forecast period to reach USD 216.8 Million by 2020.

Browse 47 market data Tables and 35 Figures spread through 122 Pages and in-depth TOC on "Fertility Testing Devices Market “

http://www.marketsandmarkets.com/Market-Reports/fertility-testing-devices-market-139945432.html
Early buyers will receive 10% customization on this report.

The emergence of advanced and easy-to-use ovulation monitors with high accuracy, rising median age of first-time pregnancies in women, and increasing awareness about fertility testing are driving the growth of the market. In addition, factors such as declining fertility rate among women across the globe and easy availability of ovulation monitors on e-commerce websites are further stimulating the growth of the market. However, the increasing inflow of generic fertility testing devices, high cost of ovulation monitors, and lack of predictive power & precision in modern ovulation prediction methods (to confirm ovulation) are restraining the growth of the market.

Get The PDF Brochure For This Report@

http://www.marketsandmarkets.com/pdfdownload.asp?id=139945432

The global fertility testing devices market is broadly categorized into two segments, namely, ovulation prediction kits and fertility monitors. The ovulation prediction kits segment accounts for the larger share of the global market, while the fertility monitors segment is expected to grow at the higher CAGR in the forecast period. The high growth of this segment is driven by the high accuracy of fertility monitors, especially in women suffering from PCOS, and increase in the number of product launches of advanced fertility monitors. The fertility monitors segment includes saliva-based monitors, urine-based monitors, and others.

Based on the type of mode of purchase, the global fertility testing devices market is divided into two segments prescription-based and non-prescription or OTC (over-the-counter) based. The non-prescription or OTC-based segment commanded the larger share of the global market. The large share of this segment is attributed to the increasing initiatives taken by market players to spread awareness on fertility, easy availability of fertility and ovulation monitors on e-commerce websites, rising preference for confidentiality and accessibility of test results, and rapid outcomes of diagnosis.

Download Sample Pages of this Report@

http://www.marketsandmarkets.com/requestsample.asp?id=139945432

Based on geography, the market is divided into North America (comprising the U.S. and Canada), Europe (comprising Germany, U.K., France, and the Rest of Europe), Asia-Pacific, and the Rest of the World. In 2015, North America held the largest share in the global fertility testing devices market, followed by Europe, Asia-Pacific, and the RoW (Rest of the World). The Asia-Pacific region is estimated to grow at the highest CAGR in the forecast period. Factors such as decreasing fertility rate, growing number of women suffering from lifestyle disorders, rising funding/investments for the development of fertility and ovulation monitors, and growing focus of both international and domestic players on the Asia-Pacific market are driving the growth of the fertility testing devices market in the Asia-Pacific region.

The key players in the fertility testing devices market include SPD Swiss Precision Diagnostics GmbH (Switzerland), Church & Dwight Co., Inc. (U.S.), Prestige Brands Holdings, Inc. (U.S.), Fairhaven Health, LLC (U.S.), HiLin Life Products, Inc. (U.S.), Fertility Focus Limited (U.K.), and Geratherm Medical AG (Germany).

About MarketsandMarkets™:

Contact:

Mr. Rohan

MarketsandMarkets™

701 Pike Street

Suite 2175, Seattle,

WA 98101, United States

Tel: 1-888-600-6441

Endoscopy Equipment Market Size, By Product, 2014–2021

The report "Endoscopy Equipment Market by Product (Endoscopes (Flexible, Rigid, Capsule), Visualization Systems, Other Endoscopy Equipment, Accessories), Application (GI Endoscopy, Laparoscopy), End User (Hospitals, ASCs/Clinics) - Trends & Forecasts to 2021” The endoscopy equipment market is projected to reach USD 35.36 Billion by 2021, growing at a CAGR of 6.2% during the forecast period of 2016 to 2021.

Browse 535 market data tables and 51 figures spread through 449 pages and in-depth TOC on “Endoscopy Equipment Market “

http://www.marketsandmarkets.com/Market-Reports/endoscopy-devices-market-689.html

Early buyers will receive 10% customization on this report.

The growth of the overall endoscopy equipment market can be attributed to rising investments, funds, and grants by government bodies worldwide; rising number of hospitals; and growing hospital investments. In addition, growing patient preference for minimally invasive surgeries, technological advancements, favorable reimbursement coverage in selected countries, rising geriatric population, and the rising prevalence of target diseases that require endoscopy procedures have contributed to the market growth.

Get The PDF Brochure For This Report@

http://www.marketsandmarkets.com/pdfdownload.asp?id=689

The global endoscopy equipment market is segmented on the basis of product, application, end user, and region.

Based on product, the endoscopy equipment market is categorized into endoscopes, visualization systems, other endoscopy equipment, and accessories. The endoscopes segment is further divided into flexible, rigid, and capsule endoscopes. The visualization systems segment include endoscopy cameras, camera heads, video convertors, transmitters & receivers, carts, and video recorders. The other endoscopy equipment is classified into other electrical endoscopy equipment and other mechanical endoscopy equipment. The accessories of endoscopy equipment include cleaning brushes, surgical dissectors, needle forceps & needle holders, fluid flushing devices, light cables, biopsy valves, mouthpiece

Based on application, the market is segmented into laparoscopy, gastrointestinal endoscopy, arthroscopy, obstetrics/gynecological endoscopy, urology endoscopy, bronchoscopy, mediastinoscopy, otoscopy, and laryngoscopy. The gastrointestinal endoscopy segment is expected to account for the largest share of the market in 2016.

Based on end user, the market is segmented into hospitals and ambulatory surgical centers (ASCs)/clinics. The hospital segment is expected to account for the largest share of the endoscopy equipment market in 2016.

Download Sample Pages of this Report@

http://www.marketsandmarkets.com/requestsample.asp?id=689

Based on region, The global market is divided into North America, Europe, Asia-Pacific, and RoW (Latin America, the Middle East, and Africa). In 2016, North America is poised to account for the largest share of the endoscopy equipment market, followed by Europe and Asia-Pacific. However, the Asia-Pacific market is projected to grow at the highest CAGR during the forecast period and serve as a major revenue pocket for companies offering endoscopy equipment.

Some major players in the global endoscopy equipment market include Ethicon, Inc. (U.S.), Olympus Corporation (Japan), Fujifilm Holdings Corporation (Japan), KARL STORZ GmbH & Co. KG (Germany), Medtronic plc (Ireland), Stryker Corporation (U.S.), Boston Scientific Corporation (U.S.), Pentax Medical Corporation (Japan), Smith & Nephew plc (U.K.), Richard Wolf GmbH (Germany), and Cook Medical Incorporated (U.S.).

About MarketsandMarkets™:

Contact:

Mr. Rohan

MarketsandMarkets™

701 Pike Street

Suite 2175, Seattle,

WA 98101, United States

Tel: 1-888-600-6441

Tuesday, 30 May 2017

Attractive Growth Opportunities in the Global Veterinary Surgical Instruments Market

The report "Veterinary Surgical Instruments Market by Product (Sutures, Foreceps, Scissors, Electro surgery Instruments, Cannulas) Animal (Canines, Felines, Large Animals) Application (Soft tissue, Sterilization, Gynecology, & Orthopedic Surgery) - Forecast to 2021", analyzes and studies the major market drivers, restraints, and opportunities in North America, Europe, Asia-Pacific, and Rest of the World.

Browse 175 market data tables and 32 figures spread through 244 pages and in-depth TOC on “Veterinary Surgical Instruments Market Forecast to 2021”
http://www.marketsandmarkets.com/Market-Reports/veterinary-surgical-instrument-market-212886010.html
Early buyers will receive 10% customization on this reports.

The global veterinary surgical instruments market is segmented based on product, animal, application, and geography.

Based on product type, the market is segmented into sutures, staplers and accessories, handheld devices, electro-surgery instruments, and others. The handheld devices are further segmented into forceps, scalpels, surgical scissors, hooks & retractors, and trocars & cannulas.

Based on animal type, the market is segmented into small animals and large animals. The small animals segment is further segmented into canines, felines, and other small animals, while the large animals segment is further segmented into equines and other large animals.

Based on the application the veterinary surgical instruments market is segmented into soft- tissue surgery, sterilization surgery, gynecology & urology, dental surgery, orthopedic surgery, ophthalmic surgery and others.

Similarly, on the basis of geography, the veterinary surgical instruments market is segmented into Europe, North-America, Asia-Pacific, and Rest of the World.

Get The PDF Brochure For This Report

http://www.marketsandmarkets.com/pdfdownload.asp?id=212886010

Geography:

North America is the largest regional segment for veterinary surgical instruments owing to the well-established animal healthcare market. The largest share of this regional segment is driven by rising companion animal adoption and healthcare expenditure, growing number of veterinary practitioners and their income levels, and rising demand for pet insurance. However, the market in the Asia-Pacific region is expected to grow at the highest CAGR, owing to rising pet adoption and increasing demand for animal-derived food products in India and China.

The market players, namely, B. Braun Vet Care GmbH (Germany), Medtronic Plc. (Ireland), Ethicon Inc. (U.S.), and JORGEN KRUSSE A/S (Denmark) held the major share of the veterinary surgical instruments market and will continue to dominate the market between 2016 and 2021.

About MarketsandMarkets

MarketsandMarkets is the largest market research firm worldwide in terms of annually published premium market research reports. Serving 1700 global fortune enterprises with more than 1200 premium studies in a year, M&M is catering to a multitude of clients across 8 different industrial verticals. We specialize in consulting assignments and business research across high growth markets, cutting edge technologies and newer applications. Our 850 fulltime analyst and SMEs at MarketsandMarkets are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors.M&M’s flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets. The new included chapters on Methodology and Benchmarking presented with high quality analytical infographics in our reports gives complete visibility of how the numbers have been arrived and defend the accuracy of the numbers.

We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.

Contact:

Mr. Rohan

MarketsandMarkets™

701 Pike Street

Suite 2175, Seattle,

WA 98101, United States

Tel: 1-888-600-6441

Friday, 26 May 2017

Pharmacovigilance and Drug Safety Software Market worth $154.1 Million by 2019

The report “Pharmacovigilance and Drug Safety Software Market by Functionality (Adverse Event Reporting, Fully Integrated Software), Delivery Mode (On-premise, On-demand/Cloud based (SAAS)), End-user (Pharma & Biotech Companies, CROs, BPOs) - Global Forecast to 2019” analyzes and studies the major market drivers, restraints, opportunities, and challenges in North America, Europe, Asia-Pacific, and the Rest of the world (RoW).

Browse 74 market data tables

and 57 figures spread through 210 pages

and in-depth TOC on “Pharmacovigilance and Drug Safety Software Market”

http://www.marketsandmarkets.com/Market-Reports/drug-safety-pharmacovigilance-software-market-16831714.html

On the basis of functionality, the global pharmacovigilance software market is classified into four major segments, namely, adverse event reporting software, drug safety audits software, issue tracking software, and fully integrated software.

The global drug safety software market is divided into two segments on the basis of delivery mode, namely, on-premise delivery mode and on-demand/cloud based (SaaS) delivery mode. This market is also divided into pharma and biotech companies, contract research organizations (CROs), business process outsourcing (BPO) firms, and other pharmacovigilance service providers on the basis of type of end user.

The global pharmacovigilance software market is expected to grow at a CAGR of 6.5% from 2014 to 2019. Factors such as increasing incidence rates of adverse drug reactions (ADRs) and growing adoption of pharmacovigilance software by organizations such as CROs and BPOs are driving the growth of the global pharmacovigilance software market. In addition; government regulatory bodies (such as the U.S. FDA and EMEA) have intensified safety regulations for prior and post commercialization of drugs, which has increased pressure on the pharmaceutical and biotechnology companies to manufacture safe drugs and evaluate their results post sales. Thus, growing complexity related to drug safety regulations is expected to drive the growth of the market during the forecast period.

Get Discount

http://www.marketsandmarkets.com/discountreports.asp?id=16831714

Geography:

North America is expected to account for the largest share of the drug safety software market, followed by Europe, in 2014. However, Asian and Latin American countries represent high growth markets, owing to a rise in research outsourcing by pharmaceutical giants and growing public and private investments in pharmaceutical R&D in these emerging nations. Some of the key players in the global pharmacovigilance software market include ArisGlobal (U.S.), Ennov Solutions Inc. (U.S.), EXTEDO GmbH (U.S.), Online Business Applications, Inc. (U.S.), Oracle Corporation (U.S.), Sarjen Systems Pvt. Ltd (India), Sparta Systems, Inc. (U.S.), and United BioSource Corporation (U.S.), among others.

ArisGlobal (U.S.), Ennov Solutions Inc. (U.S.), EXTEDO GmbH (U.S.), Online Business Applications, Inc. (U.S.), Oracle Corporation (U.S.), Sarjen Systems Pvt. Ltd (India), Sparta Systems, Inc. (U.S.), and United BioSource Corporation (U.S.) are some of the key players operating in the global drug safety software market.

About MarketsandMarkets

We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.

Contact:

Mr. Rohan

MarketsandMarkets™

701 Pike Street

Suite 2175, Seattle,

WA 98101, United States

Tel: 1-888-600-6441

Particle Counters Market worth 330.6 Million USD by 2021

The report "Particle Counters Market by Product (Airborne Particle Counters, Liquid Particle Counters), Application (Cleanroom Monitoring, Contamination Monitoring of Liquids), and End User (Healthcare Industry, Semiconductor Industry) - Global Forecast to 2021", analyzes and studies the major market drivers, restraints/challenges, and opportunities.

Browse

96 market data tables

33 figures spread through 152 pages

http://www.marketsandmarkets.com/Market-Reports/particle-counter-market-221564539.html
Early buyers will receive 10% customization on reports.

The global particle counters market is segmented on the basis of type, application, end user, and region.

On the basis of application, the global particle counters market is segmented into cleanroom monitoring, air quality monitoring, contamination monitoring of liquids, drinking water application, aerosol monitoring and research, chemical contamination monitoring, and other applications.

On the basis of end user, the global particle counters market is segmented into the healthcare industry, semiconductor industry, automotive industry, aerospace industry, food and beverage industry, and other end users. In 2016, the pharmaceutical industry is expected to account for the largest share of the global particle counters market.

Get The PDF Brochure For This Report

http://www.marketsandmarkets.com/pdfdownload.asp?id=221564539

Geography:

Based on region, the particle counters market is divided into North America, Europe, Asia-Pacific, and the Rest of the World. In 2016, North America is expected to account for the largest share of the global particle counters market. This is attributed to factors such as the growing pharmaceutical industry and increasing employment of particle counters for air pollution monitoring in the country.

Particle Measuring Systems (U.S.), Beckman Coulter (U.K.), RION Co., Ltd (Japan), Lighthouse Worldwide Solutions (U.S.), TSI (U.S.), and Climet Instruments Company (U.S.) are some of the key players in the global particle counters market.

About MarketsandMarkets

We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.

Contact:

Mr. Rohan

MarketsandMarkets™

701 Pike Street

Suite 2175, Seattle,

WA 98101, United States

Tel: 1-888-600-6441

Wednesday, 24 May 2017

Latin American Orthodontic Supplies Market worth 320.2 Million USD by 2020

The report “Latin America Orthodontic Supplies Market by Removable & Fixed Braces (Brackets (Self Ligating, Lingual), Archwire (Nickel Titanium, Stainless Steel), Anchorage Appliances (Buccal Tube, Band), Ligature (Elastomeric, Wire)) & Adhesives - Forecast to 2020”,This report studies the Latin American Orthodontic Supplies market over the forecast period of 2015 to 2020. The market is estimated at USD 245.0 Million in 2015 and is poised to grow at a CAGR of 5.5% during the forecast period, to reach USD 320.2 Million by 2020

Browse 63 market data tables and 55 figures spread through 136 pages and in-depth TOC on "Latin America Orthodontic Supplies Market “

http://www.marketsandmarkets.com/Market-Reports/latin-america-orthodontic-supplies-market-54591839.html

Early buyers will receive 10% customization on This report.

A number of factors such as the rising number of patients with malocclusions, lower cost of orthodontic treatment in Latin America (as compared to other developed nations), higher concentration of orthodontics associations, decreasing trade barriers for medical devices in some Latin American countries, and rising disposable incomes in Brazil, Mexico, and Chile are propelling the growth of the Latin America orthodontic supplies market. Moreover, growing medical tourism in Latin America, increasing adoption of orthodontic treatment, and improving socioeconomic status will provide growth opportunities for players in the region. On the other hand, risks and complications during or post-orthodontic treatments and limited reimbursement coverage for orthodontic treatments are restraining the growth of this market.

The Latin American orthodontic supplies market has been segmented into three broad segments fixed braces, removable braces, and orthodontic adhesives. The fixed braces segment is further categorized into brackets, archwires, anchorage appliances, and ligatures. The brackets market is segmented into conventional, self-ligating, and lingual braces. The archwires segment is categorized into nickel & beta titanium and stainless steel. Anchorage appliances are further segmented into buccal tubes, bands, and miniscrews, whereas the ligatures market is segmented into elastomeric and wire ligatures.

The Sample Report For This Report@

http://www.marketsandmarkets.com/requestsample.asp?id=54591839

The market is divided into Brazil, Mexico, Chile, Argentina, Peru, and the Rest of Latin America. In 2015, Brazil holds the largest market share, followed by Mexico. Chile is estimated to grow at the highest CAGR in the forecast period due to healthcare and trade-related initiatives taken by Chilean government to raise awareness and the better economic landscape in Chile (as compared to other countries).

The major players in the Latin America orthodontic supplies market include Dental Morelli Ltda. (Brazil), 3M Corporation (U.S.), American Orthodontics (U.S.), DENTSPLY International, Inc. (U.S.), Ormco Corporation (U.S.), and Orthometric (Brazil), and FORESTADENT (Germany).

Get The PDF Brochure For This Report@

http://www.marketsandmarkets.com/pdfdownload.asp?id=54591839

About MarketsandMarkets™:

Contact:

Mr. Rohan

MarketsandMarkets™

701 Pike Street

Suite 2175, Seattle,

WA 98101, United States

Tel: 1-888-600-6441

Vendor Neutral Archive & Picture Archiving and Communication System (PACS) Market worth $3.48 Billion by 2018

The "Vendor Neutral Archive Market & PACS Market - VNA [On-premise Software, Hybrid & Cloud, Multi-Department & Multi-Site VNA] & Picture Archiving and Communication System [Enterprise, Cardiology & Radiology] - Global Forecast to 2018"The global VNA market is estimated at $165.3 million in 2013 and is poised to reach $335.4 million by 2018, at a CAGR of 15.2%.

Browse 54 market data tables and 48 figures spread through 215 pages and in-depth TOC on Vendor Neutral Archive Market & PACS Market “

http://www.marketsandmarkets.com/Market-Reports/vendor-neutral-archive-VNA-PACS-market-1255.html

Early buyers will receive 10% customization on This report.

Vendor neutral archives are platforms aimed at empowering healthcare organizations to control, manage, store, and consolidate imaging data by streamlining the imaging workflow between PACS (Picture Archiving and Communication Systems), EHRs (Electronic Health Records), and data centers. Along with the global market for VNA, the PACS market is also given to provide a comparative analysis of both the healthcare information systems. The product lifecycles of each of these systems varies to a very large extent.

It is believed that the vendor neutral archives market is positioned in a phase (exponential phase) where the PACS market was around 10 to 15 years ago. The PACS market, on the other hand, is a mature market that is typically characterized by the market players trying to invest in product differentiations and looking for new customer groups.

Based on the delivery mode, the market is categorized into on-premise VNAs, hybrid VNAs, and fully cloud-hosted VNAs. On-premise VNAs dominate the current market in terms of total revenue contribution due to the high preference of this mode over others. This preference is as a result of better data control and high security provided by on-premise VNA solutions. However, owing to the large capital expenditure involved for on-premise VNAs, hybrid VNA solutions that involve a cloud-based component for storage are now capturing the attention of small and medium-sized healthcare providers.

The advantages of vendor neutral archives over picture archiving and communication system in terms of interoperability, flexibility, and accessibility are propelling the adoption of the VNA technology in the market. Apart from this, favorable and promising government reforms in the healthcare information technology field are also stimulating the market. The major hindrances to the growth of the market are rising incidences of data breaches, complexity of the VNA concept, lack of a proper industry-accepted definition of VNAs, and long VNA lifecycles (that impacts VNA deployment decisions). With this, the market is all set to witness trends such as integration of VNAs with EHRs, employment of cloud computing solutions for VNA products, and a holistic approach for delivering enhanced patient care.

The Sample Report For This Report@

http://www.marketsandmarkets.com/requestsample.asp?id=1255

North America is the largest contributor to this market and is valued at $140.3 million in 2013. Through acts such as HITECH (Healthcare Insurance Portability and Accountability) and ACA (Affordable Care), the U.S. market is expected to witness growing adoptions of EHRs and VNAs and hospital consolidations. The European market is poised to grow at a high double-digit CAGR of 16.6%, with the biggest market being U.K. owing to the presence of huge NHS trusts that purchase VNAs on a very large scale. Australia, China, and Japan are the next promising regions for embracement of this technology due to the government-supported nation-wide healthcare reforms taking place in these regions.

Key companies in this market include Acuo Technologies (U.S.), Agfa HealthCare (Belgium), BridgeHead Software (U.K.), Carestream Health (U.S.), Dell, Inc. (U.S.), GE Healthcare (U.K.), Fujifilm Corporation (Japan), Merge Health (U.S.), McKesson Corporation (U.S.), Philips Healthcare (The Netherlands), Siemens Healthcare (Germany), and TeraMedica (U.S.).

Get The PDF Brochure For This Report@

http://www.marketsandmarkets.com/pdfdownload.asp?id=1255

About MarketsandMarkets™:

Contact:

Mr. Rohan

MarketsandMarkets™

701 Pike Street

Suite 2175, Seattle,

WA 98101, United States

Tel: 1-888-600-6441

Radioimmunoassay Market worth $428.4 Million by 2020

The report "Radioimmunoassay Market by Type (Reagents & Kits, Analyzers), End User (Hospital, Pharmaceutical Industry, Academics, Clinical Diagnostic Labs), Application (Research, Clinical Diagnostics), and Geography - Global Forecast to 2020", The global radioimmunoassay (RIA) market was valued at $345.2 Million in 2014 and is expected to reach $428.4 Million by 2020, at a CAGR of 3.5% during the forecast period from 2015 to 2020.

Browse 75 market data Tables and 68 Figures spread through 113 Pages and in-depth TOC on "Radioimmunoassay Market "
http://www.marketsandmarkets.com/Market-Reports/radioimmunoassay-market-172815697.html

Early buyers will receive 10% customization on This report.

Radioimmunoassay (RIA) is an in-vitro assay technique that is used to measure the concentration of antigens in blood. RIA encompasses the separation of protein from a mixture by using the specificity of antibody- antigen binding and their quantitation by using radioactivity. The method is hypersensitive and can quantify tiny amounts of hormone or drug level with the help of antibodies.

Radioimmunoassay is used owing to its high sensitivity, which can analyze nanomolar and picomolar concentrations of hormones in biological fluids. RIA has become one of the major tools in various clinical laboratories for diagnostic procedures, such as assessing the plasma levels of most of the hormones, identifying the presence of certain abused drugs, evaluating the presence of hepatitis B surface antigen in donated blood, and others. This technique is also used for the early detection of cancer, treatment of peptic ulcers, research with neurotransmitters, detection of infections, and identification of allergens in food and house dust, and so on.

The increasing usage of RIA in pharmaceutical industries, research labs, and contract research organizations (CROs) has led to an increased demand of products that are based on this technique. Furthermore, the rising need for quality and error-free results to ensure patient satisfaction has resulted in research labs and diagnostic centers to opt for high-throughput and automated procedures. This is also one of the major factors that have resulted in the growth of the RIA market to a large extent.

There are two types of radioimmunoassay, which serve different functions for clinical diagnostics and research purposes. These types have been classified into reagents & kits and analyzers. In 2014, the reagents & kits segment contributed the largest share of 82.9% to the global radioimmunoassay market.

The various application areas of RIA are infectious disease testing, endocrine testing, allergy testing, oncology testing, toxicology testing, and autoimmune disease testing. Out of all the application segments, oncology testing is the largest application segment, and is expected to hold the major market share in the near future.

Based on this market’s end users, the global radioimmunoassay market has been segmented into hospitals (hospital-based laboratories/hospital-attached laboratories), academics, pharmaceutical industry and CROs, clinical laboratories, and others, which include physician offices, patient self-testing centers, blood banks, home health agencies, nursing homes, and ambulatory surgical centers.

The Sample Report For This Report@

http://www.marketsandmarkets.com/requestsample.asp?id=172815697

The global radioimmunoassay market has been categorized into major geographical regions, including Europe, North America, Asia, and the Rest of the world. Europe is the most dominant region in the global radioimmunoassay market, and contributed a share of 35.1% in 2014; the market in this region was valued at $121.5 Million in the same year.

Some of the major players in the radioimmunoassay globally are DIAsource ImmunoAssays SA (Belgium), Beckman Coulter, Inc. (U.S.), IBL International (A Tecan Company) (Germany), PerkinElmer, Inc. (U.S.), DRG International, Inc. (U.S.), MP Biomedicals, LLC (U.S.), Cisbio (France), Euro Diagnostica AB (Sweden), DiaSorin S.p.A.. (Italy), EMD Millipore (U.S.), Izotop (Hungary), Berthold Technologies GmbH & Co. KG (Germany), Stratec Biomedical AG (Germany), and others.

Get The PDF Brochure For This Report@

http://www.marketsandmarkets.com/pdfdownload.asp?id=172815697

About MarketsandMarkets™:

Contact:

Mr. Rohan

MarketsandMarkets™

701 Pike Street

Suite 2175, Seattle,

WA 98101, United States

Tel: 1-888-600-6441